Keller and Heckman offers global food and drug services to its clients. Our comprehensive and extensive food and drug practice is one of the largest in the world. We promote, protect, and defend products made by the spectrum of industries regulated by the U.S. Food and Drug Administration (FDA), the European Commission and Member States authorities in the European Union (EU) and similar authorities throughout the world. The products we help get to market include foods, pharmaceuticals, medical devices, veterinary products, dietary supplements, and cosmetics. In addition, we have a very comprehensive practice in the regulation of packaging materials for food, drugs, and cosmetics and other food-contact articles. We represent clients in addressing all issues relating to these products, including the suitability of their composition, inspection of manufacturing facilities, labeling and advertising, recall procedures, quality assurance programs, and appropriate responses to consumer complaints and tampering incidents. We also vigorously defend our clients when threatened by unwarranted action by competitors or regulatory authorities. We also have substantial experience conducting "due diligence" audits of marketed products, labeling, advertising claims, and manufacturing operations, both for the clients' internal control purposes and as part of product line or corporate acquisitions.
More Legal and Business Bylines From Food and Drug Law at Keller and Heckman
- FDA Updates Food Facility Registration Product Categories - (Posted On Wednesday, September 28, 2016)
- The Hullabaloo about Healthy: FDA Formally Seeks to Redefine “Healthy” - (Posted On Tuesday, September 27, 2016)
- Soda Showdown: Beverage Industry Takes Philadelphia to Court - (Posted On Monday, September 26, 2016)
- Organic Melee: USDA Loses Latest Round in Legal Challenge Over Synthetics in Organic Production - (Posted On Friday, September 23, 2016)
- Food Safety and Inspection Service Issues New Directive Addressing HPAI and Agro-Terrorism - (Posted On Thursday, September 22, 2016)
- Catfish Controversy Continues: Lawmakers Push To Upend USDA Inspection Program - (Posted On Wednesday, September 21, 2016)
- Antibiotic Ire: Groups Petition FDA to Limit Antibiotic Use in Food Animals - (Posted On Tuesday, September 20, 2016)
- FDA Issues Guidance for the Labeling of Infant Formula - (Posted On Monday, September 19, 2016)
- FDA Begins Enforcement of New Tobacco Rules - (Posted On Friday, September 16, 2016)
- FDA Seeks More Information on Antimicrobials in Animal Feed and Water - (Posted On Thursday, September 15, 2016)
Keller and Heckman’s Food and Drug Law Practice Group is a Go-To Thought Leader for 2021 for its coverage of Food Labeling Class Action Lawsuits and Regulatory news. The group regularly provides interesting, comprehensive news on topics ranging from class-action lawsuits involving Snack Foods lacking real Wasabi and Canned Green Beans inaccurately claiming to be preservative-free, to proposed federal legislation regulating CBD in food products. NLR readers appreciate the group’s efforts to break down lawsuits and pending legislation impacting the nation's food supply.
The National Law Review Recognizes Keller and Heckman’s Food and Drug Law Practice Group as Go-To Thought Leaders for the firm’s contributions on FDA Regulations and guidelines. Keller and Heckman’s expansive FDA coverage included: proposed rules expanding food traceability and record-keeping requirements, new guidance for animal food additives, a final rule concerning gluten-free food labeling, and approval of a new peanut allergy drug. Addressing the COVID-19 crisis, Keller & Heckman provided news about warnings required by the FDA for Purell and other actions about hand sanitizer and additional Coronavirus prevention and cure claims, the FDA’s and OSHA’s employee health and food safety checklist(s) and COVID-19 best practices for retail and restaurants and COVID-19 Guidance to U.S. food exporters. The firm’s most frequent FDA / Food and Drug Law attorney contributors to the NLR include Azim Chowdhury, Sheila A. Millar, Evangelia Pelonis, Natalie Rainer and LieAnn Van-Tull.